- 米国企業
- AYTU BIOPHARMA, INC
AYTU BIOPHARMA, INCAYTU
時価総額
$1375.2万
PER
2013年 8月31日 | 2015年 6月30日 | 2016年 6月30日 | 2017年 6月30日 | 2018年 6月30日 | 2019年 6月30日 | 2020年 6月30日 | 2021年 6月30日 | 2022年 6月30日 | 2023年 6月30日 | |
Cash and cash equivalents | - | 7 | 8 | 802,328 | 7 | 11 | 48 | 50 | 19 | 23 |
Accounts receivable, net | - | 157,058 | 162,427 | 528,039 | 578,782 | 2 | 5 | 28 | 22 | 29 |
Inventories | - | 39,442 | 524,707 | 1 | 1 | 1 | 10 | 16 | 11 | 12 |
Prepaid expenses | - | 370,888 | - | - | - | - | - | 10 | 7 | 8 |
Other current assets | - | - | - | - | - | - | 6 | 1 | 1 | 1 |
Total current assets | 1,862 | 8 | 10 | 3 | 9 | 15 | 75 | 105 | 60 | 73 |
Property and equipment, net | - | - | - | - | - | - | - | 5 | 3 | 2 |
Operating lease right-of-use asset | - | - | - | - | - | - | 634,093 | 4 | 3 | 2 |
Intangible assets, net | - | - | - | - | - | - | - | 85 | 71 | 59 |
Other non-current assets | - | - | 11 | 9 | 11 | 19 | 17 | 0 | 1 | 1 |
Total non-current assets | 7,807 | 10 | 14 | 12 | 12 | 19 | 78 | 160 | 78 | 64 |
Total assets | 9,669 | 18 | 24 | 15 | 21 | 35 | 153 | 266 | 138 | 136 |
Accounts payable and other | - | - | - | - | - | - | - | - | 11 | 13 |
Accrued liabilities | - | - | - | 782,536 | 185,882 | 1 | 8 | 51 | 44 | 47 |
Short-Term Debt | - | - | - | - | - | - | - | - | - | 2 |
Current portion of debt | - | - | - | - | - | - | - | 17 | 0 | 0 |
Other current liabilities | - | - | - | - | - | - | 839,734 | - | 5 | 7 |
Total current liabilities | 120,525 | 1 | 10 | 4 | 3 | 5 | 28 | 109 | 64 | 69 |
Debt, net of current portion | - | - | - | - | - | - | - | 0 | 14 | 15 |
Derivative warrant liabilities | - | - | 275,992 | - | 93,981 | 13,201 | 11,371 | - | - | 6 |
Other non-current liabilities | - | - | - | - | - | - | 5 | 0 | 13 | 7 |
Total liabilities | - | 3 | 14 | 11 | 8 | 28 | 58 | 128 | 92 | 97 |
Preferred Stock, Value, Issued | - | - | - | - | - | 359 | - | - | - | - |
Common Stock, Value, Issued | 414,027 | 1,426 | 374 | 82 | 179 | 1,754 | 12,584 | 0 | 0 | 0 |
Additional paid-in capital | 40,821 | 39 | 57 | 73 | - | - | - | - | 335 | 343 |
Accumulated deficit | -500 | -18,381,341 | -46,561,425 | -69,069,729 | -79,257,592 | -106,389,500 | -120,010,179 | -178 | -288 | -304 |
Total stockholders' equity | -110,856 | 16 | 10 | 4 | 13 | 7 | 95 | 138 | 46 | 39 |
Total liabilities and stockholders' equity | 9,669 | 18 | 24 | 15 | 21 | 35 | 153 | 266 | 138 | 136 |